FIM
PMC

Freedom Investment Management’s PharMerica Corporation PMC Stock Holding History

Freedom Investment Management’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,495
Closed -$264K – 1129
2016
Q4 		$264K Sell
10,495
-3,848
-27% -$97.1K 0.02% 750
2016
Q3 		$403K Buy
14,343
+822
+6% +$21.1K 0.03% 513
2016
Q2 		$333K Buy
+13,521
New +$336K 0.02% 551

Other funds holding PMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

Freedom Investment Management's PMC Position: Q1 2017 in Review

Freedom Investment Management sold out of PharMerica Corporation (PMC) in Q1 2017, closing a stake of 10,495 shares — an estimated $264K sold.

Freedom Investment Management first reported a position in PMC in Q2 2016 and held it in 3 quarters. The position peaked at $403K in Q3 2016. 152 funds tracked by Wall St. Rank hold PMC as of Q1 2017.

  • Freedom Investment Management reported no remaining PharMerica Corporation position as of Q1 2017 after selling out during the quarter.
  • Freedom Investment Management sold 10,495 PharMerica Corporation shares in Q1 2017, an estimated $264K.
  • Freedom Investment Management first reported a position in PharMerica Corporation in Q2 2016 and held it in 3 quarters.
  • Freedom Investment Management's PharMerica Corporation position peaked at $403K in Q3 2016.
  • 152 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2017.

Based on Freedom Investment Management's 13F filing for Q1 2017, filed 2 May 2017.